This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ewha University-Industry Collaboration Foundation. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Yea Jee Kwon: Innovator in Drug Virtual Screening
Introduction
Yea Jee Kwon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of drug discovery through his innovative approaches to virtual screening methods. His work focuses on enhancing the accuracy of drug screening processes, which is crucial for the development of effective pharmaceuticals.
Latest Patents
Yea Jee Kwon holds a patent for a "Method and system for drug virtual screening and construction of focused screening library." This invention relates to a virtual drug screening method that boasts high prediction accuracy based on various biological activities extracted from multiple drug screening data. Notably, this method does not rely on the structures or structural attribute information of target proteins or compounds. The patent also includes an intensive screening library constructing method and a system designed for this purpose. He has 1 patent to his name.
Career Highlights
Yea Jee Kwon is affiliated with the Ewha University-Industry Collaboration Foundation, where he applies his expertise in drug screening technologies. His role at this institution allows him to collaborate with other researchers and contribute to advancements in pharmaceutical sciences.
Collaborations
He has worked alongside notable colleagues such as Wan Kyu Kim and Hae Seung Lee, further enhancing the collaborative environment in which innovative drug screening methods are developed.
Conclusion
Yea Jee Kwon's contributions to drug virtual screening represent a significant advancement in the field of pharmaceuticals. His innovative methods are paving the way for more accurate and efficient drug discovery processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
